SOURCE: IDenta Corp.

June 17, 2009 13:15 ET

International Drug & Explosives Detection Firm IDenta Corp. Announces Important Marketing Trip to US and France

JERUSALEM--(Marketwire - June 17, 2009) - IDenta Corp. (PINKSHEETS: IDTA) today announced that top executives of the company, Yaacov Shoham, CEO; Baruch Glattstein, Chief Scientist; and Jacob Weiss, legal and business consultant; will be in the US and France in the next several weeks to attend important strategic meetings related to future growth of the company.

IDenta Corp CEO Yaacov Shoham states, "This business trip to the US and France is by far the most important trip since we started our company and it will help guide the future growth of IDenta as we embark on this phase of expected increased demand for our products.

"We will be in the New York area and in Paris for the following issues:

1. To start implementation with the New York-based company, the new marketing program for the previously mentioned eight retail and drug store chains.

2. Meetings with a U.S.-based private equity fund manager (a continuation of the two previous meetings held in Israel).

3. Meeting and training sessions for use of IDenta products with an unnamed security company regarding law enforcement agencies in the states, including the US Army and exploratory talks about construction of our new American manufacturing plant.

4. Meetings in France with the representatives of different French Law Enforcement agencies (customs, interior minister, national laboratories and police) to enlarge the use of our different products there, including the new General Screening Drug Test kit and Precursor Test kits. We have been invited officially and specially to this important meeting by the French authorities."

Mr. Shoham also states, "We must have our company positioned, through strong relationships, to be ready to meet the increased demand for our kits as our company matures. Many of these relationships are now in place."

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

Information concerning IDenta's entire product line may be found at www.IDenta.biz and http://www.accutest.net/.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.identa.biz.

Contact Information